Abbott Laboratories (ABT)
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
Abbott's (ABT) glucose monitoring systems - Lingo and Libre Rio - based on Freestyle Libre technology, receive FDA clearance.
2 Healthcare Stocks to Buy Hand Over Fist in June
Vertex Pharmaceuticals and Abbott Laboratories are innovative healthcare leaders. Both companies have robust businesses and excellent potential opportunities.
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Abbott (ABT) closed the most recent trading day at $105.81, moving -1.56% from the previous trading session.
2 Magnificent Dividend Growth Stocks to Buy Now
Dividend growth stocks are superb wealth-creation vehicles. These two blue chips are among the best in the category.
FDA approves two new Abbott over-the-counter continuous glucose monitors
Abbott on Monday announced it has received FDA clearance for two new CGMs that will be available without a prescription. A CGM is a small sensor that pokes through the skin and tracks a person's glucose levels in real-time.
US FDA clears Abbott's continuous glucose monitors for over-the-counter use
Abbott said on Monday that the U.S. Food and Drug Administration has cleared its two continuous glucose monitoring systems for over-the-counter use.
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
From 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during recessions. Dividends have contributed 40% of the stock market gain since 1930, increasing with rising inflation.
Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Abbott (ABT) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Abbott (ABT) stood at $103.23, denoting a -0.19% change from the preceding trading day.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
The 2 Most Important Charts I Want (Dividend) Investors To See
Recent data indicates a heightened risk of stagflation, with slowing economic growth and persistent inflation. This poses challenges for the economy and portfolios, but also presents opportunities to buy beaten-down stocks with strong pricing power and growth potential. My focus remains on resilient dividend growth stocks and sectors like energy and healthcare, which are well-positioned for these conditions.
Abbott Laboratories: Why I Agree With Wall Street On This One
Wall Street analysts have a 'strong buy' rating on ABT stock, with 12 out of 24 analysts giving it this rating in the last 90 days. We agree with such bullish sentiment. Despite some risks, ABT stock has the potential to outperform the overall market by a large margin.
